PAX5 and neoplasm: Altogether, given its pro-epithelialization role in breast tumors, PAX5 suppresses invasive properties leading to better prognostic value with a lower risk of disease progression and relapse as long as cancer cells remain in their primary tumor sites (in situ) [102].